4.8 Article

Capecitabine Can Induce T Cell Apoptosis: A Potential Immunosuppressive Agent With Anti-Cancer Effect

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Possible involvement of TRPM2 activation in 5-fluorouracil-induced myelosuppression in mice

Masaaki Ishibashi et al.

Summary: The study demonstrates that 5-FU enhances the activation of TRPM2 channel, and inhibition of H2O2-induced Ca2+ concentration increase by 5-FU in Trpm2 KO mice, alleviating the reduction of blood cells induced by 5-FU.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Article Oncology

Inositol Hexakisphosphate and Inositol Enhance the Inhibition of Colorectal Cancer Growth and Liver Metastasis by Capecitabine in a Mouse Model

Chunlei Li et al.

Summary: The study demonstrates that the combination of IP6 and INS with capecitabine significantly improves survival rate, reduces tumor weight, and inhibits liver metastasis in a mouse model of colorectal cancer. Furthermore, this combined treatment effectively modulates the expression of inflammatory factors, intercellular adhesion molecules, and vimentin, enhancing the therapeutic effect on CRC growth.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)

Article Biophysics

Doxifluridine-based pharmacosomes delivering miR-122 as tumor microenvironments-activated nanoplatforms for synergistic treatment of hepatocellular carcinoma

Fangqin Xue et al.

Summary: The novel anti-cancer pharmacosome, derived from Doxifluridine and activated by tumor microenvironments, effectively targeted tumor cells, counteracted chemotherapy resistance, and showed a synergistic effect, holding promising application prospects in the treatment of hepatocellular carcinoma (HCC).

COLLOIDS AND SURFACES B-BIOINTERFACES (2021)

Article Cell Biology

Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling

Hui Liu et al.

Summary: Tumor recurrence is a major obstacle for liver transplantation in HCC patients, with inflammatory cascades promoting recurrence. The mobilization of MDSC induced by liver graft injury plays a role in promoting HCC recurrence. Targeting MDSC mobilization via CXCL10/TLR4/MMP14 signaling may represent a potential therapeutic approach to decrease post-transplant liver tumor recurrence.

CELL DEATH & DISEASE (2021)

Review Immunology

The Immunological Basis of Liver Allograft Rejection

Vincenzo Ronca et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Medicine, General & Internal

CAR-NK cells: A promising cellular immunotherapy for cancer

Guozhu Xie et al.

EBIOMEDICINE (2020)

Review Immunology

IL-10-producing T cells and their dual functions

Tanja Bedke et al.

SEMINARS IN IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

PERK/eIF-2α/CHOP Pathway Dependent ROS Generation Mediates Butein-induced Non-small-cell Lung Cancer Apoptosis and G2/M Phase Arrest

Shouyin Di et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)

Article Medicine, Research & Experimental

Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells

David M. Peereboom et al.

JCI INSIGHT (2019)

Article Oncology

Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation

Franco Trevisani et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)

Article Cell Biology

Interleukin-6 Family Cytokines

Stefan Rose-John

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)

Review Immunology

Human T Cell Development, Localization, and Function throughout Life

Brahma V. Kumar et al.

IMMUNITY (2018)

Article Multidisciplinary Sciences

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept

Stefania De Lorenzo et al.

SCIENTIFIC REPORTS (2018)

Review Oncology

Regulation of T cell immunity by cellular metabolism

Zhilin Hu et al.

FRONTIERS OF MEDICINE (2018)

Article Pharmacology & Pharmacy

Population Pharmacokinetic-Pharmacodynamic Modeling of 5-Fluorouracil for Toxicities in Rats

Shinji Kobuchi et al.

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2017)

Review Pharmacology & Pharmacy

Emerging drugs for prevention of T-cell mediated rejection in liver and kidney transplantation

Tiffany C. L. Wong et al.

EXPERT OPINION ON EMERGING DRUGS (2017)

Article Multidisciplinary Sciences

Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy

Yin Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Physiology

Hematopoiesis in 5-Fluorouracil-Treated Adenosine A3 Receptor Knock-Out Mice

M. Hofer et al.

PHYSIOLOGICAL RESEARCH (2015)

Review Biotechnology & Applied Microbiology

Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature

Alberto Bongiovanni et al.

ONCOTARGETS AND THERAPY (2014)

Article Pharmacology & Pharmacy

Possible Involvement of Oxidative Stress in 5-Fluorouracil-Mediated Myelosuppression in Mice

Satoshi Numazawa et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2011)

Review Immunology

The regulation of IL-10 production by immune cells

Margarida Saraiva et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Review Pharmacology & Pharmacy

Capecitabine: A review

CM Walko et al.

CLINICAL THERAPEUTICS (2005)

Article Immunology

Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis

Y Hashimoto et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)

Review Pharmacology & Pharmacy

Clinical pharmacokinetics of capecitabine

B Reigner et al.

CLINICAL PHARMACOKINETICS (2001)